Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Turn Therapeutics Inc shares valued at $33,946 were purchased by GOLDEN ARTHUR F on Nov 24 ’25. At $3.44 per share, GOLDEN ARTHUR F acquired 9,868 shares. The insider’s holdings grew to 60,602 shares worth approximately $0.21 million following the completion of this transaction.
Also, GOLDEN ARTHUR F purchased 20,532 shares, netting a total of over 58,927 in proceeds. Following the buying of shares at $2.87 each, the insider now holds 50,734 shares.
Before that, Chaudhary Zuraiz had added 1,450 shares to its account. In a trade valued at $3,784, the insider bought Turn Therapeutics Inc shares for $2.61 each. Upon closing the transaction, the insider’s holdings increased to 1,450 shares, worth approximately $30600.0.
Analyzing TTRX Stock Performance
On last trading session, Turn Therapeutics Inc [NASDAQ: TTRX] rose 3.03% to $3.4. The stock’s lowest price that day was $3.3412, but it reached a high of $3.49 in the same session. During the last five days, there has been a surge of approximately 20.14%.
Support And Resistance Levels for Turn Therapeutics Inc (TTRX)
According to the 24-hour chart, there is a support level at 3.33, which, if violated, would cause prices to drop to 3.26. In the upper region, resistance lies at 3.48. The next price resistance is at 3.56. RSI (Relative Strength Index) is 39.20 on the 14-day chart, showing neutral technical sentiment.
Is Turn Therapeutics Inc subject to short interest?
Stocks of Turn Therapeutics Inc saw a sharp steep in short interest on 2025-11-14 dropping by 25640.0 shares to 0.1 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 0.13 million shares. A decline of -25.27% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.35 of the overall float, the days-to-cover ratio (short ratio) decline to 0.35.
